Mapping the ligand of the NK inhibitory receptor Ly49A on living cells

被引:28
作者
Chung, DH
Natarajan, K
Boyd, LF
Tormo, J
Mariuzza, RA
Yokoyama, WM
Margulies, DH
机构
[1] NIAID, Immunol Lab, Mol Biol Sect, NIH, Bethesda, MD 20892 USA
[2] CSIC, Ctr Nacl Biotecnol, Madrid, Spain
[3] Univ Maryland, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA
[4] Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA
关键词
D O I
10.4049/jimmunol.165.12.6922
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have used a recombinant, biotinylated form of the mouse NK cell inhibitory receptor, Ly49A, to visualize the expression of MHC class I (MHC-I) ligands on living lymphoid cells. A panel of murine strains, including MHC congenic lines, was examined. We detected binding of Ly49A to cells expressing H-2D(d), H-2D(k), and H-2D(P) but not to those expressing other MHC molecules, Cells of the MHC-recombinant strain B10,PL (M-2(u)) not only bound Ly49A but also inhibited cytolysis by Ly49A(+) effector cells, consistent with the correlation of in vitro binding and NK cell function. Binding of Ly49A to H-2D(d)-bearing cells of different lymphoid tissues was proportional to the level of H-2Dd expression and was not related to the lineage of the cells examined, These binding results, interpreted in the context of amino acid sequence comparisons and the recently determined three-dimensional structure of the Ly49A/H-2D(d) complex, suggest a role for amino acid residues at the amino-terminal end of the alpha1 helix of the MHC-I molecule for Ly49A interaction. This view is supported by a marked decrease in affinity of an H-2D(d) mutant, 152 M, for Ly49A. Thus, allelic variation of MHC-I molecules controls measurable affinity for the NK inhibitory receptor Ly49A and explains differences in functional recognition in different mouse strains.
引用
收藏
页码:6922 / 6932
页数:11
相关论文
共 74 条
  • [1] FINE MAPPING OF EPITOPES BY INTRADOMAIN KD/DD RECOMBINANTS
    ABASTADO, JP
    JAULIN, C
    SCHUTZE, MP
    LANGLADEDEMOYEN, P
    PLATA, F
    OZATO, K
    KOURILSKY, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (02) : 327 - 340
  • [2] Characterization of terminal sialic acid linkages on human thymocytes - Correlation between lectin-binding phenotype and sialyltransferase expression
    Baum, LG
    Derbin, K
    Perillo, NL
    Wu, T
    Pang, M
    Uittenbogaart, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) : 10793 - 10799
  • [3] PROTEIN DATA BANK - COMPUTER-BASED ARCHIVAL FILE FOR MACROMOLECULAR STRUCTURES
    BERNSTEIN, FC
    KOETZLE, TF
    WILLIAMS, GJB
    MEYER, EF
    BRICE, MD
    RODGERS, JR
    KENNARD, O
    SHIMANOUCHI, T
    TASUMI, M
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1977, 112 (03) : 535 - 542
  • [4] FUNCTIONAL EXPRESSION OF A HETEROLOGOUS MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I GENE IN TRANSGENIC MICE
    BIEBERICH, C
    YOSHIOKA, T
    TANAKA, K
    JAY, G
    SCANGOS, G
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (11) : 4003 - 4009
  • [5] Signal transduction by human NK cell MHC-recognizing receptors
    Binstadt, BA
    Brumbaugh, KM
    Leibson, PJ
    [J]. IMMUNOLOGICAL REVIEWS, 1997, 155 : 197 - 203
  • [6] Natural killer cells in antiviral defense: Function and regulation by innate cytokines
    Biron, CA
    Nguyen, KB
    Pien, GC
    Cousens, LP
    Salazar-Mather, TP
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 189 - 220
  • [7] Structure of CD94 reveals a novel C-type lectin fold: Implications for the NK cell-associated CD94/NKG2 receptors
    Boyington, JC
    Riaz, AN
    Patamawenu, A
    Coligan, JE
    Brooks, AG
    Sun, PD
    [J]. IMMUNITY, 1999, 10 (01) : 75 - 82
  • [8] Brooks AG, 1999, J IMMUNOL, V162, P305
  • [9] CHADWICK BS, 1992, J IMMUNOL, V148, P2307
  • [10] CHAN PY, 1989, J IMMUNOL, V142, P1727